148 related articles for article (PubMed ID: 26615421)
1. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
[TBL] [Abstract][Full Text] [Related]
2. CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
Gao D; Hu H; Wang Y; Yu W; Zhou J; Wang X; Wang W; Zhou C; Xu K
Oncol Rep; 2015 Dec; 34(6):2853-63. PubMed ID: 26503336
[TBL] [Abstract][Full Text] [Related]
3. Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer Patients.
Yan M; Zhu X; Qiao H; Zhang H; Xie W; Cai J
DNA Cell Biol; 2021 Jun; 40(6):791-797. PubMed ID: 33978454
[TBL] [Abstract][Full Text] [Related]
4. CMTM8 is Frequently Downregulated in Multiple Solid Tumors.
Zhang W; Qi H; Mo X; Sun Q; Li T; Song Q; Xu K; Hu H; Ma D; Wang Y
Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):122-128. PubMed ID: 26574634
[TBL] [Abstract][Full Text] [Related]
5. Knocking down glycoprotein nonmetastatic melanoma protein B suppresses the proliferation, migration, and invasion in bladder cancer cells.
Zhang YX; Qin CP; Zhang XQ; Wang QR; Zhao CB; Yuan YQ; Yang JG
Tumour Biol; 2017 Apr; 39(4):1010428317699119. PubMed ID: 28443476
[TBL] [Abstract][Full Text] [Related]
6. Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
Bao Y; Liu X; Liu Y; Wang S; Wu B
Surg Oncol; 2019 Sep; 30():63-71. PubMed ID: 31500788
[TBL] [Abstract][Full Text] [Related]
7. Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
Asai A; Miyata Y; Takehara K; Kanda S; Watanabe SI; Greer PA; Sakai H
J Cancer Res Clin Oncol; 2018 Jan; 144(1):21-31. PubMed ID: 28952025
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.
Zhang S; Li J; Zhou G; Mu D; Yan J; Xing J; Yao Z; Sheng H; Li D; Lv C; Sun B; Hong Q; Guo H
Tumour Biol; 2016 Apr; 37(4):5165-70. PubMed ID: 26547586
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
Li M; Cai Y; Zhao H; Xu Z; Sun Q; Luo M; Gu L; Meng M; Han X; Sun H
Tumour Biol; 2015 Jun; 36(6):4785-92. PubMed ID: 25647262
[TBL] [Abstract][Full Text] [Related]
10. CMTM8 Is a Suppressor of Human Mesenchymal Stem Cell Osteogenic Differentiation and Promoter of Proliferation Via EGFR Signaling.
H'ng CH; Camp E; Anderson PJ; Zannettino ACW; Gronthos S
Stem Cells Dev; 2020 Jul; 29(13):823-834. PubMed ID: 32268840
[TBL] [Abstract][Full Text] [Related]
11. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of CMTM8 and E-cadherin in primary and metastatic clear cell renal cell carcinoma].
Hu H; Chen JW; Xu KX; Wang D; Wang Y; Wang GW; Zhang SY; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):537-41. PubMed ID: 23939157
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
Zhu YD; Lu MY
Mol Med Rep; 2018 Sep; 18(3):3403-3410. PubMed ID: 30066919
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑663b downregulation inhibits proliferation and induces apoptosis in bladder cancer cells by targeting TUSC2.
Chen J; Song B; Kong G
Mol Med Rep; 2019 May; 19(5):3896-3902. PubMed ID: 30896880
[TBL] [Abstract][Full Text] [Related]
15. Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.
Wu D; Lin J; Zhu Y; Zhang H; Zhong Y
Med Sci Monit; 2019 Jul; 25():5289-5298. PubMed ID: 31310599
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
Liu Y; Wang H; Zhong J; Wu C; Yang G; Zhong Y; Zhang J; Tang A
BMC Cancer; 2018 Jun; 18(1):642. PubMed ID: 29880037
[TBL] [Abstract][Full Text] [Related]
17. Influence of CMTM8 polymorphisms on lung cancer susceptibility in the Chinese Han population.
Wu J; Sun Y; Xiong Z; Niu F; Liu Y; Li H; Liu J; Wu J; Liu Q; Jin T
Pharmacogenet Genomics; 2021 Jun; 31(4):89-95. PubMed ID: 33395025
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous nuclear ribonucleoprotein K is associated with poor prognosis and regulates proliferation and apoptosis in bladder cancer.
Chen X; Gu P; Xie R; Han J; Liu H; Wang B; Xie W; Xie W; Zhong G; Chen C; Xie S; Jiang N; Lin T; Huang J
J Cell Mol Med; 2017 Jul; 21(7):1266-1279. PubMed ID: 27862976
[TBL] [Abstract][Full Text] [Related]
19. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
Wu J
Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
Lin YL; Wang YL; Ma JG; Li WP
J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]